Select Page

LLUH introduces a revolutionary single anesthesia procedure combining lung cancer diagnosis and removal
“An innovative approach has emerged that combines the diagnosis and removal of lung cancer into a single anesthesia event. This new technique reduces patient stress and inconvenience but also expedites the diagnosis and treatment process for lung nodules. Loma Linda University Health is the only medical center in the region to offer this service.”

Can an AI Model Improve Mortality Risk Prediction Linked to Lung Cancer or Cardiovascular Disease?
“A novel artificial intelligence (AI) model may be able to accurately predict the risk of death from lung cancer, cardiovascular disease, and other causes by using data from low-dose computed tomography (CT) scans of the lungs, according to a recent study published by Xu et al in Radiology.”

Lung Cancer Trials Require Modified Eligibility Criteria to Better Reflect Real-World Population
“The evolution of clinical trial enrollment criteria to more accurately represent real-world lung cancer populations will be contingent on cooperation and innovation from members of the entire oncology community, including researchers, community oncologists, and trial sponsors, according to Edward S. Kim, MD, MBA.”

Sugemalimab Plus Chemotherapy Yields Statistically Significant Improvement in OS and PFS in NSCLC
“Sugemalimab in combination with chemotherapy demonstrated statistically significant and clinically meaningful improvements in progression-free survival (PFS) and overall survival (OS) vs placebo plus chemotherapy for the first-line treatment of patients with stage IV non–small cell lung cancer (NSCLC) with no known EGFR, ALK, ROS1, or RET aberrations, irrespective of PD-L1 expression level and tumor pathological type, according to findings from the phase 3 GEMSTONE-302 (NCT03789604) trial published in Nature Cancer.

Investigators Set Sights on Novel Agents Following Negative Studies in Relapsed Small Cell Lung Cancer
“New agents in development including ABBV-011 and BL-B01D1 seek to turn the tides of relapsed extensive-stage small cell lung cancer (ES-SCLC), explained Primo “Lucky” Lara Jr., MD, who added that although chemoimmunotherapy has earned its right as the frontline standard of care, both classes of agents have yet to demonstrate benefit in second or later lines.”

Garsorasib Results Add to the Growing Group of KRASG12C Inhibitors in NSCLC
“Early results with garsorasib (D-1553) showed the potential for the oral KRASG12C inhibitor in patients with advanced non–small cell lung cancer (NSCLC) and provided the rationale to move ahead to a phase 2 trial, according to data published in the Journal of Thoracic Oncology.”

Comparing LDCT Lung Cancer Screening Effectiveness in Asian Female Never-Smokers and Asian Male Ever-Smokers
“Globally, lung cancer in never-smokers is the leading cause of cancer-related mortality. Using a systematic review and meta-analysis, researchers compared the efficacy of low-dose computed tomography (LDCT) lung cancer screening in never-smokers versus smokers. PubMed and Scopus were searched for LDCT lung cancer screening studies that included both ever-smokers and never-smokers and were published by April 30, 2021.”

Just a few minutes of vigorous physical activity a day significantly reduces cancer risk
“Small amounts of vigorous intermittent lifestyle physical activity appeared associated with lower risk for cancer, according to a study published in JAMA Oncology.”

Liquid biopsy cuts time to treatment by 37% for those with suspected advanced lung cancer
“Circulating tumor DNA genotyping before tissue diagnosis of suspected advanced non-small cell lung cancer resulted in significantly shorter median time to treatment compared with standard tissue testing, study results showed.”

Cancer Survivors Are Stronger Together
“The world has become a divisive place. What used to be healthy discussions of differing opinions have become, in some cases, arguments that polarize family and friends. Race, history, even books have become fair game for creating a “you-vs-them” mentality. I know we will get through these stormy seas in time, and that time can’t come soon enough for most of us.”

My grandmother died of lung cancer. Please stop blaming her for it
“I recently opened Instagram and saw a video of someone walking past a smoker and choking aggressively and exaggeratedly to try to make them feel bad.